|
⚲
|
| Keyboard |
| Metzger Michael A
✚
|
|
|---|---|
| CIK # | 0001507220 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001507220] | |
| 4 | [0001507220] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Syndax Pharmaceuticals Inc | |
| Metzger Michael A | |
| Pyxis Oncology Inc | |
| CTI Biopharma Corp | |
| Regado Biosciences Inc | |
| Response Genetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2026-03-24 | Grant | 45,867 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2026-02-09 | Sell | 17,159 | $21.03 | 360,854 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2026-02-06 | Sell | 7,412 | $20.62 | 152,835 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2026-02-04 | Grant | 144,600 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2026-02-04 | Grant | 73,000 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
|
2026-02-04 | Grant | 440,000 | $20.43 | 8,989,200 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-07-16 | Sell | 7,534 | $9.29 | 69,991 |
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Grant | 36,979 | $0.98 | 36,239 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-03-14 | Option exercise | 6,074 | $7.20 | 43,733 |
|
Syndax Pharmaceuticals Inc SNDX
Stock options (Right to buy) · derivative
|
2025-03-14 | Option exercise | 6,074 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-03-04 | Sell | 7,814 | $15.05 | 117,601 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-03-04 | Option exercise | 7,814 | $7.20 | 56,261 |
|
Syndax Pharmaceuticals Inc SNDX
Stock options (Right to buy) · derivative
|
2025-03-04 | Option exercise | 7,814 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-02-10 | Sell | 13,288 | $15.50 | 205,964 |
|
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
|
2025-02-05 | Grant | 364,000 | $14.65 | 5,332,600 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-02-05 | Grant | 89,000 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-02-05 | Grant | 60,500 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2024-06-10 | Grant | 70,683 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2024-02-07 | Grant | 107,250 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2024-02-07 | Grant | 39,000 | $0.00 | |
| showing 20 of 148 most recent transactions | |||||